Page last updated: 2024-08-21

quinazolines and telcagepant

quinazolines has been researched along with telcagepant in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's14 (53.85)29.6817
2010's12 (46.15)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arndt, K; Doods, H; Just, S; Rudolf, K1
Edvinsson, L; Kuris, A; Link, AS1
Ashina, M; Jensen, RH1
Stillman, MJ; Tepper, SJ1
Davis, CD; Xu, C1
Benemei, S; Capone, JG; Geppetti, P; Nicoletti, P1
Burgey, CS; Salvatore, CA; Williams, TM1
Nieber, K1
Tfelt-Hansen, PC1
Olesen, J; Villalón, CM1
Bigal, ME; Ho, TW1
Vetter, C1
Barwell, J; Donnelly, D; Garland, SL; Miller, PS; Poyner, DR; Wigglesworth, MJ1
Paone, DV; Staas, DD1
Paemeleire, K; Schelstraete, C1
Gingell, JJ; Hay, DL; Kane, SA; Moore, EL; Salvatore, CA1
Edvinsson, L; Ho, TW1
Durham, PL; Vause, CV1
Fischer, MJ1
Abdul-Manan, N; Coll, JT; Garcia-Guzman, M; Koth, CM; Lepre, CA; Lippke, JA; Moore, JM; Swenson, L; ter Haar, E1
Olesen, J; Tfelt-Hansen, P1
Lionetto, L; Martelletti, P; Negro, A; Simmaco, M1
Edvinsson, L; Warfvinge, K1
Anderson, C; Bergeron, D; Binch, H; Decker, C; Garcia-Guzman, M; Hadida, S; Joshi, P; Moore, J; terHaar, E; Termin, A; Yoo, S1
Abdolalizadeh, B; Amandi, N; Edvinsson, L; Pickering, DS; Pla, MV; Sams, A; Sheykhzade, M; Warfvinge, K1
Goadsby, PJ; Messina, R1

Reviews

16 review(s) available for quinazolines and telcagepant

ArticleYear
CGRP antagonists: unravelling the role of CGRP in migraine.
    Trends in pharmacological sciences, 2007, Volume: 28, Issue:11

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Models, Biological; Molecular Structure; Quinazolines

2007
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system.
    The journal of headache and pain, 2008, Volume: 9, Issue:1

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebral Arteries; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Trigeminal Nerve; Tryptamines; Vasodilation

2008
Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine.
    Headache, 2008, Volume: 48, Issue:8

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Drug Evaluation, Preclinical; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines

2008
The tortuous road to an ideal CGRP function blocker for the treatment of migraine.
    Current topics in medicinal chemistry, 2008, Volume: 8, Issue:16

    Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Structure-Activity Relationship; Vasodilation

2008
CGRP receptors in the control of pain and inflammation.
    Current opinion in pharmacology, 2009, Volume: 9, Issue:1

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Neurogenic Inflammation; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide

2009
Calcitonin gene-related peptide receptor antagonists for the treatment of migraine.
    Progress in medicinal chemistry, 2009, Volume: 47

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Drug Design; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Species Specificity; Structure-Activity Relationship

2009
[CGRP antagonists: novel concept for treatment of migraine].
    Medizinische Monatsschrift fur Pharmazeuten, 2009, Volume: 32, Issue:5

    Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Quinazolines; Receptors, Calcitonin Gene-Related Peptide

2009
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
    Pharmacology & therapeutics, 2009, Volume: 124, Issue:3

    Topics: Analgesics; Animals; Azepines; Brain; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Drug Delivery Systems; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide

2009
Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent review.
    Expert opinion on therapeutic patents, 2009, Volume: 19, Issue:12

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Drug Design; Drug Industry; Humans; Imidazoles; Migraine Disorders; Patents as Topic; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide

2009
CGRP antagonists: hope for a new era in acute migraine treatment.
    Acta neurologica Belgica, 2009, Volume: 109, Issue:4

    Topics: Azepines; Brain; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines

2009
CGRP receptor antagonism and migraine.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2010, Volume: 7, Issue:2

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Neurotransmitter Agents; Piperazines; Quinazolines

2010
Calcitonin gene-related peptide receptor antagonists for migraine.
    Expert opinion on investigational drugs, 2010, Volume: 19, Issue:7

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Indazoles; Migraine Disorders; Piperazines; Quinazolines; Quinazolinones; Treatment Outcome; Trigeminal Nerve

2010
Possible site of action of CGRP antagonists in migraine.
    Cephalalgia : an international journal of headache, 2011, Volume: 31, Issue:6

    Topics: Animals; Azepines; Blood-Brain Barrier; Bridged Bicyclo Compounds, Heterocyclic; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebrovascular Circulation; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Spiro Compounds

2011
CGRP receptor antagonists: an expanding drug class for acute migraine?
    Expert opinion on investigational drugs, 2012, Volume: 21, Issue:6

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Drug Design; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Tryptamines

2012
CGRP receptor antagonism and migraine therapy.
    Current protein & peptide science, 2013, Volume: 14, Issue:5

    Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Humans; Imidazoles; Migraine Disorders; Peptide Fragments; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide

2013
CGRP - a target for acute therapy in migraine: Clinical data.
    Cephalalgia : an international journal of headache, 2019, Volume: 39, Issue:3

    Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials, Phase II as Topic; Dipeptides; Drug Delivery Systems; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide

2019

Other Studies

10 other study(ies) available for quinazolines and telcagepant

ArticleYear
[A new therapeutic principle for migraine].
    Ugeskrift for laeger, 2008, Mar-17, Volume: 170, Issue:12

    Topics: Azepines; Calcitonin Gene-Related Peptide; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Serotonin Receptor Agonists; Treatment Outcome; Triazoles; Tryptamines; Vasodilator Agents

2008
Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.
    The journal of headache and pain, 2009, Volume: 10, Issue:6

    Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cerebral Arteries; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Serotonin Receptor Agonists; Treatment Failure; Tryptamines

2009
Is there an inherent limit to acute migraine treatment efficacy?
    The journal of headache and pain, 2009, Volume: 10, Issue:6

    Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Drug Administration Schedule; Endpoint Determination; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Serotonin Receptor Agonists; Time Factors; Treatment Outcome; Tryptamines

2009
[Migraine can signal a risk for heart and brain].
    MMW Fortschritte der Medizin, 2009, Sep-10, Volume: 151, Issue:37

    Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Dipeptides; Female; Humans; Imidazoles; Migraine Disorders; Migraine with Aura; Myocardial Infarction; Piperazines; Quinazolines; Risk Factors; Stroke; Tryptamines

2009
Non-peptidic antagonists of the CGRP receptor, BIBN4096BS and MK-0974, interact with the calcitonin receptor-like receptor via methionine-42 and RAMP1 via tryptophan-74.
    Biochemical and biophysical research communications, 2010, Jan-01, Volume: 391, Issue:1

    Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Methionine; Piperazines; Protein Structure, Tertiary; Quinazolines; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Tryptophan

2010
Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
    Biochemical and biophysical research communications, 2010, Mar-26, Volume: 394, Issue:1

    Topics: Azepines; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Crystallography, X-Ray; Dipeptides; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Proteins; Migraine Disorders; Piperazines; Protein Interaction Domains and Motifs; Protein Interaction Mapping; Quinazolines; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Proteins; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Tryptophan

2010
Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine.
    CNS drugs, 2010, Volume: 24, Issue:7

    Topics: Azepines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Clinical Trials as Topic; Dipeptides; Humans; Imidazoles; Migraine Disorders; Piperazines; Quinazolines; Treatment Outcome

2010
Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism.
    Structure (London, England : 1993), 2010, Sep-08, Volume: 18, Issue:9

    Topics: Azepines; Binding Sites; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Crystallography, X-Ray; Imidazoles; Piperazines; Protein Structure, Tertiary; Quinazolines; Receptors, Calcitonin Gene-Related Peptide

2010
Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.
    Bioorganic & medicinal chemistry letters, 2014, Feb-01, Volume: 24, Issue:3

    Topics: Animals; Azepines; Calcitonin Gene-Related Peptide; Dipeptides; Humans; Imidazoles; Inhibitory Concentration 50; Migraine Disorders; Molecular Structure; Molecular Weight; Piperazines; Protein Binding; Quinazolines; Quinazolinones; Rats; Receptors, Calcitonin Gene-Related Peptide; Thiazolidinediones; Urea

2014
Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
    Vascular pharmacology, 2017, Volume: 90

    Topics: Aged; Aged, 80 and over; Animals; Azepines; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Calcitonin Receptor-Like Protein; Cerebellum; Cerebral Arteries; Dipeptides; Dose-Response Relationship, Drug; Endothelial Cells; Female; Humans; Imidazoles; In Vitro Techniques; Ligands; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Myography; Piperazines; Piperidines; Protein Binding; Pyridines; Quinazolines; Radioligand Assay; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptors, Calcitonin Gene-Related Peptide; Spiro Compounds; Sus scrofa; Vasodilation; Vasodilator Agents

2017